Cognitive disorders in amyotrophic lateral sclerosis
https://doi.org/10.14412/2074-2711-2023-2-68-74
Abstract
Cognitive disorders (CD) are observed in more than half of patients with amyotrophic lateral sclerosis (ALS), but rarely reach the degree of dementia. Currently, a classification of ALS has been proposed depending on the presence of cognitive and/or behavioral disorders. CD in ALS can be represented by speech fluency disorders, various aphasic disorders, disorders of regulatory functions, social cognitive functions, and verbal memory. The most diagnostically sensitive are special scales, such as the Edinburgh Cognitive and Behavioral Impairment Screening Scale for ALS. CD in ALS have a negative impact on the outcome of the disease and the quality of life of patients and their families. This issue requires further study.
About the Authors
M. A. Kutlubaev
Bashkir State Medical University, Ministry of Health of Russia
Russian Federation
Competing Interests:
Russian Federation
3, Lenina St., Ufa 450008
Competing Interests:
The investigation has not been sponsored. There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors.
D. K. Areprintceva
Bashkir State Medical University, Ministry of Health of Russia
Russian Federation
Competing Interests:
Russian Federation
3, Lenina St., Ufa 450008
Competing Interests:
The investigation has not been sponsored. There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors.
E. V. Pervushina
Bashkir State Medical University, Ministry of Health of Russia
Russian Federation
Competing Interests:
Russian Federation
3, Lenina St., Ufa 450008
Competing Interests:
The investigation has not been sponsored. There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors.
L. V. Brylev
V.M. Buyanov Moscow City Clinical Hospital
Russian Federation
Competing Interests:
Russian Federation
26, Bakinskaya St., Moscow 115516
Competing Interests:
The investigation has not been sponsored. There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors.
References
1. Rusina R, Vandenberghe R, Bruffaerts R. Cognitive and Behavioral Manifestations in ALS: Beyond Motor System Involvement. Diagnostics (Basel). 2021 Mar 30;11(4):624. doi: 10.3390/diagnostics11040624
2. Lomen-Hoerth C, Anderson T, Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology. 2002 Oct 8;59(7):1077-9. doi: 10.1212/wnl.59.7.1077
3. Strong MJ, Grace GM, Freedman M, et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009 Jun;10(3):131-46. doi: 10.1080/17482960802654364. Erratum in: Amyotroph Lateral Scler. 2009 Aug;10(4):252.
4. Kutlubaev MA, Pervushina EV, Areprintceva DK, et al. Neuropsychiatric presentations of amyotrophic lateral sclerosis. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(5):36-42. doi: 10.17116/jnevro202212205136 (In Russ.).
5. Strong MJ, Abrahams S, Goldstein LH, et al. Amyotrophic lateral sclerosis -frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener. 2017 May;18(3-4):153-74. doi: 10.1080/21678421.2016.1267768. Epub 2017 Jan 5.
6. Beeldman E, Raaphorst J, Klein Twennaar M, et al. The cognitive profile of ALS: a systematic review and meta-analysis update. J Neurol Neurosurg Psychiatry. 2016 Jun;87(6):611-9. doi: 10.1136/jnnp-2015-310734. Epub 2015 Aug 17.
7. De Marchi F, Carrarini C, De Martino A, et al; SIgN. Cognitive dysfunction in amyotrophic lateral sclerosis: can we predict it? Neurol Sci. 2021 Jun;42(6):2211-22. doi: 10.1007/s10072-021-05188-0. Epub 2021 Mar 27.
8. Aiello EN, Pain D, Radici A, et al. Cognition and motor phenotypes in ALS: a retrospective study. Neurol Sci. 2022 Sep;43(9):5397-402. doi: 10.1007/s10072-022-06157-x. Epub 2022 May 24.
9. Yunusova Y, Ansari J, Ramirez J, et al. Frontal Anatomical Correlates of Cognitive and Speech Motor Deficits in Amyotrophic Lateral Sclerosis. Behav Neurol. 2019 Mar 13;2019:9518309. doi: 10.1155/2019/9518309
10. Kasper E, Schuster C, Machts J, et al. Dysexecutive functioning in ALS patients and its clinical implications. Amyotroph Lateral Scler Frontotemporal Degener. 2015 Jun;16(3-4):160-71. doi: 10.3109/21678421.2015.1026267. Epub 2015 May 12.
11. Ceslis A, Argall R, Henderson RD, et al. The spectrum of language impairments in amyotrophic lateral sclerosis. Cortex. 2020 Nov;132:349-360. doi: 10.1016/j.cortex.2020.09.003. Epub 2020 Sep 18.
12. Pinto-Grau M, Hardiman O, Pender N. The Study of Language in the Amyotrophic Lateral Sclerosis – Frontotemporal Spectrum Disorder: a Systematic Review of Findings and New Perspectives. Neuropsychol Rev. 2018 Jun;28(2):251-68. doi: 10.1007/s11065-018-9375-7. Epub 2018 Apr 28.
13. Lillo P, Caramelli P, Musa G, et al. Inside minds, beneath diseases: social cognition in amyotrophic lateral sclerosis-frontotemporal spectrum disorder. J Neurol Neurosurg Psychiatry. 2020 Dec;91(12):1279-82. doi: 10.1136/jnnp-2020-324302. Epub 2020 Sep 22.
14. Ahmed RM, Devenney EM, Strikwerda-Brown C, et al. Phenotypic variability in ALS-FTD and effect on survival. Neurology. 2020 May 12;94(19):e2005-e2013. doi: 10.1212/WNL.0000000000009398. Epub 2020 Apr 10.
15. Quarta E, Bravi R, Scambi I, et al. Increased anxiety-like behavior and selective learning impairments are concomitant to loss of hippocampal interneurons in the presymptomatic SOD1(G93A) ALS mouse model. J Comp Neurol. 2015 Aug 1;523(11):1622-38. doi: 10.1002/cne.23759
16. Machts J, Keute M, Kaufmann J, et al. Longitudinal clinical and neuroanatomical correlates of memory impairment in motor neuron disease. Neuroimage Clin. 2021;29:102545. doi: 10.1016/j.nicl.2020.102545. Epub 2020 Dec 25.
17. Bersano E, Sarnelli MF, Solara V, et al. Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study. Amyotroph Lateral Scler Frontotemporal Degener. 2020 Aug;21(5-6):373-9. doi: 10.1080/21678421.2020.1771732. Epub 2020 Jun 2.
18. Consonni M, Dalla Bella E, Bersano E, Lauria G. Cognitive and behavioural impairment in amyotrophic lateral sclerosis: A landmark of the disease? A mini review of longitudinal studies. Neurosci Lett. 2021 May 29;754:135898. doi: 10.1016/j.neulet.2021.135898. Epub 2021 Apr 15.
19. Costello E, Rooney J, Pinto-Grau M, et al. Cognitive reserve in amyotrophic lateral sclerosis (ALS): a population-based longitudinal study. J Neurol Neurosurg Psychiatry. 2021 May;92(5):460-5. doi: 10.1136/jnnp-2020-324992. Epub 2021 Feb 9.
20. Temp AGM, Kasper E, Machts J, et al. Cognitive reserve protects ALS-typical cognitive domains: A longitudinal study. Ann Clin Transl Neurol. 2022 Aug;9(8):1212-23. doi: 10.1002/acn3.51623. Epub 2022 Jul 22.
21. Chio A, Moglia C, Canosa A, et al. Cognitive impairment across ALS clinical stages in a population-based cohort. Neurology. 2019 Sep 3;93(10):e984-e994. doi: 10.1212/WNL.0000000000008063. Epub 2019 Aug 13.
22. Lee SE, Sias AC, Mandelli ML, et al. Network degeneration and dysfunction in presymptomatic C9ORF72 expansion carriers. Neuroimage Clin. 2016 Dec 10;14:286-97. doi: 10.1016/j.nicl.2016.12.006
23. Chenji S, Ishaque A, Mah D, et al; Canadian ALS Neuroimaging Consortium (CALSNIC). Neuroanatomical associations of the Edinburgh cognitive and Behavioural ALS screen (ECAS). Brain Imaging Behav. 2021 Jun;15(3):1641-54. doi: 10.1007/s11682-020-00359-7
24. Agosta F, Ferraro PM, Riva N, et al. Structural brain correlates of cognitive and behavioral impairment in MND. Hum Brain Mapp. 2016 Apr;37(4):1614-26. doi: 10.1002/hbm.23124. Epub 2016 Feb 2.
25. Consonni M, Dalla Bella E, Contarino VE, et al. Cortical thinning trajectories across disease stages and cognitive impairment in amyotrophic lateral sclerosis. Cortex. 2020 Oct;131:284-94. doi: 10.1016/j.cortex.2020.07.007. Epub 2020 Jul 29.
26. Illan-Gala I, Montal V, Pegueroles J, et al. Cortical microstructure in the amyotrophic lateral sclerosis-frontotemporal dementia continuum. Neurology. 2020 Nov 3;95(18):e2565-e2576. doi: 10.1212/WNL.0000000000010727. Epub 2020 Sep 10.
27. Dimond D, Ishaque A, Chenji S, et al. White matter structural network abnormalities underlie executive dysfunction in amyotrophic lateral sclerosis. Hum Brain Mapp. 2017 Mar;38(3):1249-68. doi: 10.1002/hbm.23452. Epub 2016 Oct 31.
28. McMackin R, Dukic S, Costello E, et al. Cognitive network hyperactivation and motor cortex decline correlate with ALS prognosis. Neurobiol Aging. 2021 Aug;104:57-70. doi: 10.1016/j.neurobiolaging.2021.03.002. Epub 2021 Mar 10.
29. Hu T, Hou Y, Wei Q, et al. Patterns of brain regional functional coherence in cognitive impaired ALS. Int J Neurosci. 2020 Aug;130(8):751-8. doi: 10.1080/00207454.2019.1705806. Epub 2020 Jan 6.
30. Temp AGM, Dyrba M, Büttner C, et al. Cognitive Profiles of Amyotrophic Lateral Sclerosis Differ in Resting-State Functional Connectivity: An fMRI Study. Front Neurosci. 2021 Jun 23;15:682100. doi: 10.3389/fnins.2021.682100
31. Canosa A, Pagani M, Cistaro A, et al. 18F-FDG-PET correlates of cognitive impairment in ALS. Neurology. 2016 Jan 5;86(1):44-9. doi: 10.1212/WNL.0000000000002242. Epub 2015 Nov 20.
32. Bella ED, Bersano E, Bruzzone MG, et al. Behavioral and Cognitive Phenotypes of Patients With Amyotrophic Lateral Sclerosis Carrying SOD1 Variants. Neurology. 2022 Aug 19;99(18):e2052-62. doi: 10.1212/WNL.0000000000201044. Epub ahead of print.
33. Brenner D, Freischmidt A. Update on genetics of amyotrophic lateral sclerosis. Curr Opin Neurol. 2022 Oct 1;35(5):672-7. doi: 10.1097/WCO.0000000000001093. Epub 2022 Aug 8.
34. Van Blitterswijk M, DeJesus-Hernandez M, Niemantsverdriet E, et al. Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study. Lancet Neurol. 2013 Oct;12(10):978-88. doi: 10.1016/S1474-4422(13)70210-2. Epub 2013 Sep 5.
35. Geser F, Lee VM, Trojanowski JQ. Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a spectrum of TDP-43 proteinopathies. Neuropathology. 2010 Apr;30(2):103-12. doi: 10.1111/j.1440-1789.2009.01091.x. Epub 2010 Jan 25.
36. Brettschneider J, Del Tredici K, Toledo JB, et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol. 2013 Jul;74(1):20-38. doi: 10.1002/ana.23937. Epub 2013 Jun 19.
37. Ahmed RM, Phan K, Highton-Williamson E, et al. Eating peptides: biomarkers of neurodegeneration in amyotrophic lateral sclerosis and frontotemporal dementia. Ann Clin Transl Neurol. 2019 Jan 31;6(3):486-95. doi: 10.1002/acn3.721
38. Steinacker P, Huss A, Mayer B, et al. Diagnostic and prognostic significance of neurofilament light chain NF-L, but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: Data from the German MND-net. Amyotroph Lateral Scler Frontotemporal Degener. 2017 Feb;18(1-2):112-9. doi: 10.1080/21678421.2016.1241279. Epub 2016 Nov 5.
39. Tremolizzo L, Pellegrini A, Conti E, et al. BDNF Serum Levels with Respect to Multidimensional Assessment in Amyotrophic Lateral Sclerosis. Neurodegener Dis. 2016;16(3-4):192-8. doi: 10.1159/000441916. Epub 2016 Jan 9.
40. Veasey SC, Davis CW, Fenik P, et al. Longterm intermittent hypoxia in mice: protracted hypersomnolence with oxidative injury to sleepwake brain regions. Sleep. 2004 Mar 15;27(2):194-201. doi: 10.1093/sleep/27.2.194
41. Taule T, Sovik M, Lein RK, et al. Psychometric Properties of Cognitive Assessment in Amyotrophic Lateral Sclerosis: A Systematic Review. Patient Relat Outcome Meas. 2020 Sep 22;11:181-94. doi: 10.2147/PROM.S256828
42. Chernenkaya VYu, Gorbachev KV, Gorbachev DV, et al. The Edinburgh Cognitive and Behavioral ALS Screen (ECAS): a Russian version. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(12):36-9. doi: 10.17116/jnevro201811812136 (In Russ.).
43. Kutlubaev MA, Caga J, Xu Y, et al. Apathy in amyotrophic lateral sclerosis: systematic review and meta-analysis of frequency, correlates, and outcomes. Amyotroph Lateral Scler Frontotemporal Degener. 2023 Feb;24(1-2):14-23. doi: 10.1080/21678421.2022.2053721. Epub 2022 Mar 30.
44. Salah AB, Pradat PF, Villain M, et al. Anosognosia in amyotrophic lateral sclerosis: A cross-sectional study of 85 individuals and their relatives. Ann Phys Rehabil Med. 2021 Sep;64(5):101440. doi: 10.1016/j.rehab.2020.08.004. Epub 2021 Sep 24.
45. Kacem I, Abida Y, Ferchichi W, et al. Arabic adaptation of the Edinburgh cognitive and behavioural Amyotrophic lateral sclerosis screen (ECAS-AR). Rev Neurol (Paris). 2022 Oct;178(8):817-25. doi: 10.1016/j.neurol.2021.12.015. Epub 2022 May 13.
46. Poletti B, Solca F, Carelli L, et al. The validation of the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener. 2016 Oct-Nov;17(7-8):489-98. doi: 10.1080/21678421.2016.1183679. Epub 2016 May 24.
47. Beeldman E, Govaarts R, de Visser M, et al. Screening for cognition in amyotrophic lateral sclerosis: test characteristics of a new screen. J Neurol. 2021 Jul;268(7):2533-40. doi: 10.1007/s00415-021-10423-x. Epub 2021 Feb 6.
48. McMillan CT, Wuu J, Rascovsky K, et al. Defining cognitive impairment in amyotrophic lateral sclerosis: an evaluation of empirical approaches. Amyotroph Lateral Scler Frontotemporal Degener. 2022 Nov;23(7-8):517-26. doi: 10.1080/21678421.2022.2039713. Epub 2022 Mar 7.
49. Ohdake R, Watanabe H, Kawabata K, et al. Convenient Auditory-Based Language and Executive Function Test for Patients With Amyotrophic Lateral Sclerosis: A Pilot Study. Arch Clin Neuropsychol. 2023 Jan 21;38(1):57-71. doi: 10.1093/arclin/acac069
50. Aiello EN, Pain D, Radici A, et al. A verb-naming test accurately detects cognitive changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2022 Nov;23(7-8):630-3. doi: 10.1080/21678421.2022.2085512. Epub 2022 Jun 15.
51. Danel-Brunaud V, Touzet L, Chevalier L, et al. Ethical considerations and palliative care in patients with amyotrophic lateral sclerosis: A review. Rev Neurol (Paris). 2017 May;173(5):300-307. doi: 10.1016/j.neurol.2017.03.032. Epub 2017 May 4. Erratum in: Rev Neurol (Paris). 2018 Jan 31.
52. Masrori P, van Damme P. Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol. 2020 Oct;27(10):1918-29. doi: 10.1111/ene.14393. Epub 2020 Jul 7.
53. Johnson SA, Fang T, De Marchi F, et al. Pharmacotherapy for Amyotrophic Lateral Sclerosis: A Review of Approved and Upcoming Agents. Drugs. 2022 Sep;82(13):1367-88. doi: 10.1007/s40265-022-01769-1. Epub 2022 Sep 19.
Review
For citations:
Kutlubaev MA, Areprintceva DK, Pervushina EV, Brylev LV. Cognitive disorders in amyotrophic lateral sclerosis. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2023;15(2):68-74. (In Russ.) https://doi.org/10.14412/2074-2711-2023-2-68-74
Views:
433
Email this article 